APA

Béliveau R., Gingras D., Kruger E. A., Lamy S., Sirois P., Simard B., Sirois M. G., Tranqui L., Baffert F., Beaulieu E., Dimitriadou V., Pépin M., Courjal F., Ricard I., Poyet P., Falardeau P., Figg W. D. & Dupont E. (20020812). The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Chicago

Béliveau Richard, Gingras Denis, Kruger Erwin A, Lamy Sylvie, Sirois Pierre, Simard Bryan, Sirois Martin G, Tranqui Leone, Baffert Fabienne, Beaulieu Edith, Dimitriadou Violetta, Pépin Marie-Claude, Courjal Frank, Ricard Isabelle, Poyet Patrick, Falardeau Pierre, Figg William D and Dupont Eric. 20020812. The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Harvard

Béliveau R., Gingras D., Kruger E. A., Lamy S., Sirois P., Simard B., Sirois M. G., Tranqui L., Baffert F., Beaulieu E., Dimitriadou V., Pépin M., Courjal F., Ricard I., Poyet P., Falardeau P., Figg W. D. and Dupont E. (20020812). The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects. : Clinical cancer research : an official journal of the American Association for Cancer Research.

MLA

Béliveau Richard, Gingras Denis, Kruger Erwin A, Lamy Sylvie, Sirois Pierre, Simard Bryan, Sirois Martin G, Tranqui Leone, Baffert Fabienne, Beaulieu Edith, Dimitriadou Violetta, Pépin Marie-Claude, Courjal Frank, Ricard Isabelle, Poyet Patrick, Falardeau Pierre, Figg William D and Dupont Eric. The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects. : Clinical cancer research : an official journal of the American Association for Cancer Research. 20020812.